About Our Company
About Our Company
Our Vision
Management
Corporate Information
Our History
About Our Business
Business Model
R&D Pipelines
News
Policy
Privacy Policy
Anonymously Processing Informations
IR News
IR News
Management Information
IR Library
Other IR Information
FAQ
Japanese
TOP
>
News
News
2024.09.09
news
Presentation of the pharmacological action of PAI-1 inhibitor RS5614 in non-small cell lung cancer at the 2024 World Conference on Lung Cancer (WCLC) in San Diego
2024.09.03
news
Notice of publication of a newspaper article in Kahoku Shimpo regarding malignant melanoma treatment drug
2024.06.05
news
Notice of Publication of Article on Immune Checkpoint Inhibitory Effect of PAI-1 Inhibitor RS5614
2024.01.19
news
Notice of Publication of Article Related to the Development of RS5614, a PAI-1 Inhibitor for the Treatment of Non-Small Cell Lung Cancer
2024.01.03
news
Notice of Publication of Article on Results of Late Phase II Study of Novel Coronavirus Lung Injury
2023.11.13
news
Notice of Publication of Article on Cutaneous Angiosarcoma Phase II Study Protocol
2023.09.29
news
Notice of Publication of Article Related to the Development of RS5614, a PAI-1 Inhibitor, for the Treatment of Malignant Melanoma
2023.09.01
news
Notice of Publication of Article on Our Pipeline in Global Bio Investment Magazine
2023.08.16
news
Nihon Keizai Shimbun Published the Article on the Results of Phase II Malignant Melanoma Study
2023.06.15
news
Notice of Publication of Article on Software as a Medical Device for Medical Support of Maintenance Hemodialysis
1
2
3
4
5
»